Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations (Unaudited)

v3.24.3
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Revenue
Operating expenses        
Research and development 2,292,040 2,158,167 6,794,426 5,365,641
General and administrative 437,011 344,758 1,133,230 1,126,192
Total operating expenses 2,729,051 2,502,925 7,927,656 6,491,833
Loss from operations (2,729,051) (2,502,925) (7,927,656) (6,491,833)
Interest Income 60,338 111,136 179,066 346,769
Net loss $ (2,668,713) $ (2,391,789) $ (7,748,590) $ (6,145,064)
Per share information:        
Net loss per common share, basic $ (0.20) $ (0.19) $ (0.60) $ (0.48)
Net loss per common share, diluted $ (0.20) $ (0.19) $ (0.60) $ (0.48)
Weighted average common shares outstanding, basic 13,142,457 12,848,165 12,970,048 12,848,165
Weighted average common shares outstanding, diluted 13,142,457 12,848,165 12,970,048 12,848,165